| Literature DB >> 33187049 |
Asad Ullah1, Sidra Munir1, Syed Lal Badshah1, Noreen Khan1, Lubna Ghani2, Benjamin Gabriel Poulson3, Abdul-Hamid Emwas4, Mariusz Jaremko3.
Abstract
Flavonoids are phytochemical compounds present in many plants, fruits, vegetables, and leaves, with potential applications in medicinal chemistry. Flavonoids possess a number of medicinal benefits, including anticancer, antioxidant, anti-inflammatory, and antiviral properties. They also have neuroprotective and cardio-protective effects. These biological activities depend upon the type of flavonoid, its (possible) mode of action, and its bioavailability. These cost-effective medicinal components have significant biological activities, and their effectiveness has been proved for a variety of diseases. The most recent work is focused on their isolation, synthesis of their analogs, and their effects on human health using a variety of techniques and animal models. Thousands of flavonoids have been successfully isolated, and this number increases steadily. We have therefore made an effort to summarize the isolated flavonoids with useful activities in order to gain a better understanding of their effects on human health.Entities:
Keywords: antioxidative; flavonoids; neuroprotective; polyphenols; quercetin
Mesh:
Substances:
Year: 2020 PMID: 33187049 PMCID: PMC7697716 DOI: 10.3390/molecules25225243
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure of flavonoids and its different types.
Figure 2Flavonoid compound isolated from Sinopodophylli fructus.
Figure 3Chemical structure of 4′-hydroxy-6,7-methylenedioxy-3-methoxyflavone.
Figure 4Chemical structure of dihydroxy-8-methoxyflavone (wogonin).
Flavonoids with anticancer properties.
| Isolated from | Isolated Flavonoids | Total Flavonoid Content | Type of Cancer | Mechanism of Action | Anticancer Assay | Ref. |
|---|---|---|---|---|---|---|
| Milk thistle ( | Silybin or silibinin | N/A | cervical (HeLa) and hepatoma (Hep3B) human cancer cells | Inhibits hypoxia-inducible factor-1a and mTOR/p70S6K/4E-BP1 signaling pathway | N/A | [ |
| Silybin | Modified Flavonoids | N/A | human bladder cancer HTB9, colon cancer HCT116 and prostate carcinoma PC3 cells | silybin strongly synergizes human prostate carcinoma cells to doxorubicin-, cisplatin-, carboplatin-, and mitoxantrone-induced growth inhibition and apoptotic death | N/A | [ |
|
| Silybin nanosuspension | N/A | human prostatic carcinoma PC-3 cell line | silybin nanosuspension induced PC-3 cell growth inhibition and Silybin nanosuspension-induced apoptosis may occur in the G1 phase. | N/A | [ |
|
| Silibinin | N/A | MCF-7 breast cancer cells. | blocks rapamycin signaling with a concomitant reduction in translation initiation | N/A | [ |
|
| N/A | N/A | prostate (PC3 and PC3-M) and breast (MCF-7) cancer cells | N/A | N/A | [ |
|
| N/A | N/A | HeLa and MCF-7 | N/A | N/A | [ |
| Onions, Kale, French beans, lettuce etc | Quercetin | N/A | ovarian PA-1 cancer cell line | quercetin induces the mitochondrial-mediated apoptotic pathway, and thus, it inhibits the growth of 17 metastatic ovarian cancer cells | N/A | [ |
|
| Erbascoside, chlorogenic acid, andapigenin7-glucoside | Total flavonoids | N/A | N/A | N/A | [ |
| N/A | human breast cancer cell line MCF-7 | anti-angiogenic activity via inhibition of blood constituents density in vessels | SRB assay | [ | ||
| N/A | N/A | human cancer cell lines (colon cancer cell line SW480, liver cancer cell line HepG2, cervical cancer line HeLa, and lung cancer line A549 | N/A | MTT assay | [ | |
|
| N/A | N/A | pancreatic β cell line MIN-6 cells | Nuclear factor-κB inhibition | N/A | [ |
Flavonoids having antioxidant effects.
| Plant (Family)—Local Name | Part of Plant | Phytochemical Screening | Total FC | Methods Used Antioxidant Assay | Values of Antioxidant Assay | Bioactivity | Ref. |
|---|---|---|---|---|---|---|---|
| Leaves | Flavonoid glycosides, carboxylic acid steroids, cardiac glycosides, terpenoids, steroidal compounds, alkaloids, saponins | N/A | DPPH | N/A | Antidiabetic, Hypolipidemic, Antifungal, Antibacterial, Anti-inflammatory, Antioxidant, Wound Healing | [ | |
| Caryopsis | Phytosterols, vitamin B group and polyphenols, and polyphenols | N/A | DPPH | (Bramo) 15.25 ± 0.07, (Serang) 25.37 ± 0.07, Menthi (28.15 ± 0.19) | Antioxidant | [ | |
|
| peel | Vitamins, and flavonoids including catechin, epicatechin, and gallocatechin | N/A | DPPH, FRAP | DPPH (165.75 ± 1.57) FRAP (1609.56 ± 90.88) | Antioxidant | [ |
| Leaves and fruits | Terpenoids, phenolic compound, tannin, flavonoids, triterpenes and saponin | N/A | DAPPH | (Leaves) 82% at 50 ppm (Fruit ) 77% at 25 ppm | Antioxidant | [ | |
| Rose water | Saponins, triterpenoids, tannins, fixed oil flavonoids | Reducing Power Ability (RPA) | 3.612 | Antioxidant, Skin protecting effect | [ | ||
| Leaves | Anthraquinone, and saponins, erpenoids and alkaloids | 11–222.67 mg QE/g | beta carotene bleaching assay. | 56.79% inhibition of Beta carotene at 200 ug/mL | Antibacterial, Anticancer, Antioxidant | [ | |
| Roots | N/A | 1.62 ± 0.05 mg QE/g | DPPH | 42–90% | Antioxidant, metal ion chelating ability | [ | |
| Whole plant | Tinocordioside, cordifolide A, palmatine, quercetin, heptacosanol, and syringin | 18.91 ± 0.21 mg QE/g | DPPH, MC, FRAP, SA, NO | 60–80% | Antibacterial, antifungal, antioxidant, anti-inflammatory activity | [ | |
| Roots | flavonoids, saponins, terpenoids, and phenolics | flavonoid 35 (97.35 mg QE/g) contents | DPPH | (% RSC) 90.93 ± 0.66 | Antioxidant and inhibitor of AChE, BChE | [ |
Figure 5Chemical structure of luteolin.
Figure 6Lead compound of flavonolignan exhibiting antioxidant and antidiabetic activity.
Flavonoids having cardio protective effects.
| Plants Whose FCC Have Cardio Protective Effect | Myocardial Injury | Animal/Cell Line Used for Experiment | In-Vivo/Ex-Vivo | Mechanism | Ref. | |
|---|---|---|---|---|---|---|
| Isoproterenol (ISO) | Male Wistar Rats | In-vivo | activation of PI3K/Akt signaling pathway | [ | ||
| Ischemia Reperfusion-induced | Male Sprague-Dawley rats | In-vivo | TFDM halted myocardial apoptosis as mediated by the PI3K/Akt/GSK-3β and ERK1/2 signaling pathways. | [ | ||
| Rutin | ischemia-reperfusion (MI/R) | Male Sprague-Dawley rats | In-vivo | SIRT1/Nrf2 signaling pathway is a possible therapeutic target for the treatment of oxidative stress and apoptosis related myocardial diseases | [ | |
| N/A | Blood | E-vivo | the extracts produced anti-inflammatory effect due to surface area/volume ratio of cells, and this can be obtained through an extension of membrane or the reduction of the cells volume and an interaction with membrane proteins | [ | ||
| cervical decapitation | Hypercholesterolemic mice | In vitro | TNF-a, IL-1b and IL-6 significantly decreased | [ | ||
|
| Intragastric ISO | Male Sprague-Dawley (SD) | In vivo and In vitro | TFCC safeguard in myocardial injury and increases the cellular antioxidant defense power by stimulating the phosphorylation of AKT, which subsequently triggered the Nrf2/HO-1 signaling pathway | [ | |
|
| Hypoxia/Reoxygenation | H9c2 cell line | In vitro | Halt the cell apoptosis, which is possibly mediated by changes in the expression of miR-21, PTEN/Akt, and Bcl/Bax. | [ | |
| isoproterenol (ISO)-induced MI | Sprague-Dawley rats | In vivo | attenuate the NF-κB signaling pathway, depress the expressions of TNF-α, IL-6, IL-1β, and PLA2 | [ | ||
|
| Myocardial Ischemia/Reperfusion | Sprague-Dawley rat | In vivo | Inhibition of UTR and the further blocking of RhoA/ROCK signaling pathway. | [ | |
| ischemia/reperfusion | Male Wistar rats | In vitro | NO release, Nrf2 pathway, and antioxidant activity resulted into lowering of apoptotic index | N/A | [ | |
| doxorubicin induced cardiac damage | Male Wistar rats | In vitro | pathological biochemical markers like creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), serum glutamic oxaloacetic transaminase (SGOT), total cholesterol, triglycerides, uric acid, calcium, nitric oxide and melanoldehyde, and significantly raises the levels of endogenous protective antioxidant proteins | uric acid ( | [ |
Flavonoids with Anti-Alzheimer’s effect.
| Type of Flavonoid | Inhibition | Lead Compound | Mechanism | Ref. |
|---|---|---|---|---|
| Galangin, kaempferol, quercetin, myricetin, fisetin, apigenin, luteolin and rutin | BChE | Galangin | Docking study showed that flavonoids bind to the BChE active site by forming multiple hydrogen bonds and π-π interactions. | [ |
| 7-Aminoalkyl-Substituted Flavonoid Derivatives | AChE and BChE | 2-(naphthalen-1-yl)-7-(8-(pyrrolidin-1-yl) octyloxy)-4 | Compound targeted Catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE | [ |
| AChE and BChE | flavonoids apigenin 7- | N/A | [ | |
|
| AChE and BChE | Colored chia seeds | Rich in polyphenols, quercetin and 23 isoquercetin with a positive correlation with inhibition of ChEs activity | [ |
|
| AChE and BChE | Leaves and rhizome of plant extracts | Presence of phytochemicals such as flavonoid and phenols | [ |
|
| AChE and BChE | pimpinellin (66.55%) and umbelliferone (40.99%) | N/A | [ |
| Arceuthobium | AChE and BChE | Ethanolic Plant extract | Higher flavonoid phenol content exhibited higher inhibition by protecting the brain against oxidative stress | [ |
| Salvia (sage) species | cholinesterase inhibition | Dichloromethane and ethanol extracts of the aerial parts of Salvia cryptantha | Strong inhibitory activity of the CH2Cl2 extract of aerial parts of | [ |
| Woundwort plants (Stachys species) flavonoids | AChE (MeOH), BChE inhibitory (EtOAc) |
| Apigenin, Hesperidin and Kaempferol have a positive correlation with inhibition of AChE and BChE | [ |
Figure 8Kaempferol identified in Stachys cretica.
Anti-inflammatory activity of Flavonoid’s.
| Plant (Family)—Local Name | Part of Plant | Phytochemical Constituents | Isolated Compounds | Assay | Flavonoid Inhibition | Mechanism | Biological Activity | Ref. |
|---|---|---|---|---|---|---|---|---|
| Lotus plumule (Nymphaeaceae) | Fresh plant | Alkaloids and flavonoids, polysaccharides, tannins, proteins and fats | N/A | Cell viability assay, Griess reagent protocol, enzyme-linked immunosorbent assay | N/A | Inhibit the production of NO radicals, PGE2 and TNF-α and pro-inflammatory cytokines IL-1β and IL-6 | Antioxidant and anti-inflammatory | [ |
| Dried powder | Phenolic acids, lignans, polyacetylenes, polysaccharide, sterols, triterpenes, sesquiterpene lactones, and alkaloids | flavonoids, saponins, polysaccharides, essential oil, coumarin and alkaloids | Nitric oxide (NO) and IL-6 measurement Quantitative real-time PCR analysis, Western blot | Flavonoids 94.2% NO inhibition | Flavonoids, saponin and essential oil inhibit NO production | Anti-inflammation, anti-cancer and anti-atherosclerosis | [ | |
| Lychee ( | Dried Seeds | oligosaccharides, phenolics, flavonoids | fifteen flavonoids | NO inhibitory assay | IC50 of Extracted flavonoid 43.56 ± 2.17 μM | N/A | Anti-inflammatory and antioxidant | [ |
| Fresh leaves | triterpenoids, flavonoids, and their glycosides, the anthraquinone glycosides, phenolic derivatives, and tannins | triterpenoids betulinic acid, koetjapic acid, flavonoids vitexin, tiliroside, kaempferol | In vivo rat model of acute λ-carrageenan-induced paw oedema | Vitexin (27.97 ± 0.01% inhibition of COX-1 and 45.35 ± 0.01 of COX-2 at 200 μg/mL), (kaempferol) 9.89 ± 0.02 COX1 ± COX-2 49.25 ± 0.02, (tiliroside) COX-1 19.79 ± 0.00, COX-2 37.59 ± 0.01 | potent inhibition of COX-2 than COX-1 reaction | Anti-inflammation | [ | |
| naringenin, naringenin chalcone, and quercetin | arachidonic acid-(AA) and tetradecanoylphorbol-13-acetate-(TPA) induced ear edema | anti-inflammatory and antiallergic activity | [ | |||||
| Branches | acridone alkaloids, tetranorterpenoids, coumarins, limonoids, and sesquiterpenes | N/A | albumin denaturation, membrane stabilization, and antiproteinase activity | The | It is possible that bioactive compounds in the extract protect lysosomal membranes activation of phospholipases. for the anti-inflammatory activity of | Antioxidant, anti-inflammatory | [ | |
| Herb | N/A | Four flavonoid compounds | Bioassay using rats | Inhibitory activities with IC50 values being in the range of 2.29 e3.03 mM. | N/A | anti-inflammatory activities, inhibitory activities against aldose reductase | [ | |
| Dried peel | Flavonoids, Phenolic acids | N/A | Levels of iNOS and COX-2 mRNA in RAW 264.7 cells were measured using RT-PCR | N/A | highest content of nobiletin and tangeretin, also produced a strong affinity to inhibit iNOS and COX-2 expression in LPS and IFN-c induced Raw 264.7 cells. We attribute this observation to the presence of a greater number of methoxy groups in nobiletin compared to the other flavonoid species studied. | antioxidant and anti-inflammatory | [ | |
| Black mulberry ( | Fruit | N/A | N/A | ELISA to detect the pro-inflammatory cytokines IL-1β, TNF-α, IFN-γ, and NO in the serum of mice | inhibitory activities of proinflammatory cytokines | Antinociceptive, Anti-inflammatory | [ | |
| Juice | Neohesperidin, naringin, melitidin, neoeriocitrin, hesperetin, naringenin | N/A | N/A | Inhibit intestinal inflammation by reducing: ROS/RNS production—inflammatory NF-κB and MAPKs pathways—pro-inflammatory cytokines levels and neutrophil infiltration—adhesion molecules expression—oxidative and nitrosative stress—tissue injury | Anti-inflammatory and antioxidant activities | [ |
Figure 9Chemical structures of glabranine and 7-O-methyl-glabranine.
Figure 10Flavonoids of Bridelia extract.
Figure 11Chemical structure of 2′,4′-dihydroxy-5′-(1‴,1‴-dimethylallyl)-8-prenyl pinocembrin (8PP).